ISRG vs PANW: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Palo Alto Networks, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+130.4% upside to fair value
Grade B High Quality
VS
Palo Alto Networks, Inc. Β· Technology
$174.96
+15.2% upside to fair value
Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+130.4%). ISRG trades at a lower forward P/E (53.8x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG PANW
Current Price $451.29 $174.96
Fair Value Estimate $1,039.74 $201.61
Upside to Fair Value +130.4% +15.2%
Market Cap $160.3B $119.2B
Forward P/E 53.8x 94.9x
EV / EBITDA 40.5x 52.4x
Price / Sales 15.2x 12.1x
Price / FCF 64.3x 29.3x
Revenue Growth YoY +23.0% +14.9%
Gross Margin 66.3% 73.5%
Operating Margin 30.5% 14.4%
Return on Equity 17.0% 15.5%
Dividend Yield 0% 0%
FCF Yield 1.55% 3.41%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
PANW β€” Palo Alto Networks, Inc.
Palo Alto Networks is a leading cybersecurity company specializing in AI-driven cloud security platforms, subscription services, and hardware products. The company benefits from a durable competitive moat driven by its platform transformation under CEO Nikesh Arora, with over 50% of revenue from high-margin subscription services growing at 25.6% year-over-year in fiscal 2024. Despite a premium va…
Accumulation Zones
Metric ISRG PANW
Zone Low $779.81 $151.21
Zone High $883.78 $171.37
In Buy Zone? Yes No
← ISRG Research    PANW Research β†’    All Research